How Much Transferred Fat Actually Survives a BBL, and Why

Ask ten patients what percentage of fat survives a Brazilian Butt Lift and you will hear numbers from 30 percent to 90 percent. Both extremes can be true in individual cases, which is exactly why the question deserves a mechanistic answer rather than a marketing one. Fat grafting is a biological transplant, and transplants follow rules.

What the injected fat is actually doing

Transferred fat is living tissue removed from its blood supply. For roughly the first 48 hours after injection, grafted fat cells survive by plasmatic imbibition, meaning they absorb oxygen and nutrients directly from the surrounding tissue fluid. This only works over very short distances, generally under 2 millimeters from a nutrient source. Fat placed in thick, dense clumps outruns that distance, and the cells at the center of the clump die.

Between roughly day 2 and day 4, a process called inosculation begins: tiny blood vessels in the graft start connecting with vessels in the recipient tissue. From about day 4 onward, true revascularization takes over as new capillaries grow into the graft. By around week 8 to week 12, the fat that has established a blood supply is essentially permanent tissue. The fat that has not is broken down and cleared by the immune system, which is why the buttock visibly shrinks between month one and month three.

This timeline explains the standard clinical advice: the result you see at three to six months is close to the result you will keep, assuming stable body weight.

The numbers research actually supports

Published studies on gluteal fat grafting, mostly using volumetric imaging or 3D surface scanning, report long term retention in a broad band of roughly 50 to 80 percent of injected volume. That spread is not sloppiness in the literature. It reflects real variables that differ between patients and between surgical techniques.

A few of the most influential factors:

Injection technique. Fat deposited in many small threads across multiple passes and planes within the subcutaneous space maximizes surface contact with vascularized tissue. Large single-pass boluses reduce survival and, when placed near or into muscle, historically carried the risk of fat entering deep gluteal veins. Current safety guidance from major plastic surgery task forces calls for subcutaneous placement only, which also happens to be favorable for graft take because the subcutaneous layer is well vascularized and low pressure.

Harvest and processing. Fat is fragile. High suction pressures, aggressive cannula trauma, prolonged exposure to air, and harsh washing all lower the fraction of viable adipocytes before injection even begins. Gentler harvest and closed-system processing tend to deliver a higher proportion of living cells, though no single processing method has proven decisively superior in comparative trials.

Recipient site capacity. Tissue can only accept so much volume before interstitial pressure rises and chokes off the microcirculation the graft depends on. This is why responsible surgeons talk about a per-session ceiling rather than a single dramatic transfer. Overfilling does not create a bigger result. It creates more dead fat, more oil cysts, and more firm nodules of fat necrosis.

Patient physiology and behavior. Smoking and nicotine constrict small vessels during the exact window when the graft is fighting for blood supply. Significant weight loss after surgery shrinks the surviving graft, because transplanted fat behaves like fat from its donor site: if the patient loses weight, it loses volume too. Direct sustained pressure in the first two to three weeks, such as long uninterrupted sitting, is widely believed to compromise perfusion in the compressed zone, which is the rationale behind sitting modifications early on, though high quality comparative data on exact sitting protocols is thin.

What overcorrection is, and what it is not

Because some volume loss is expected, surgeons often inject somewhat more than the final target. This is a calibrated adjustment, not a license to overfill. The graft-to-capacity relationship is not linear: past a certain point, adding more fat lowers the percentage that survives, so the extra volume is partly wasted and partly converted into complications. If a consultation frames enormous single-session volumes as a survival strategy, that framing is backwards.

The practical takeaway

A realistic mental model looks like this: expect visible deflation over the first three months, expect roughly half to three quarters of the injected volume to remain long term, and understand that your own behavior during the revascularization window meaningfully affects where in that range you land. Stable weight, no nicotine, pressure management early on, and a surgeon who prioritizes subcutaneous, multi-thread placement over headline volume are the levers that biology actually responds to. Everything else is noise.

Related reading: How Much Fat Does a BBL Need? Donor Sites, Volume, and the Limits of Transfer.